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The specification of an axon and its subsequent
outgrowth are key steps during neuronal polariza-
tion, a prerequisite to wire the brain. The Rho-guano-
sine triphosphatase (GTPase) RhoA is believed to be
a central player in these processes. However, its
physiological role has remained undefined. Here, ge-
netic loss- and gain-of-function experiments com-
bined with time-lapse microscopy, cell culture, and
in vivo analysis show that RhoA is not involved in
axon specification but confines the initiation of
neuronal polarization and axon outgrowth during
development. Biochemical analysis and super-
resolution microscopy together with molecular and
pharmacological manipulations reveal that RhoA
restrains axon growth by activating myosin-II-
mediated actin arc formation in the growth cone
to prevent microtubules from protruding toward
the leading edge. Through this mechanism, RhoA
regulates the duration of axon growth and pause
phases, thus controlling the tightly timed extension
of developing axons. Thereby, this work unravels
physiologically relevant players coordinating actin-
microtubule interactions during axon growth.
INTRODUCTION
Neurons undergo vivid morphological transitions during their
development. From simple, round postmitotic cells, neurons
polarize to generate subcompartments that later differentiate
into sophisticated structures [1, 2]. Initial polarization is marked
by axon formation [3, 4]. This process involves axon specifica-
tion, singling out one among multiple neurites to become the
axon and the subsequent execution of the polarity program by
elongation of the specified neurite. How neurons coordinate
axon specification and the execution of neuronal polarity is still
unclear [5, 6].
Pioneering work identified the actin cytoskeleton as a key
regulator of neuronal polarization and suggested that a dense
actin network at the tip of the neurites could restrain axon3874 Current Biology 29, 3874–3886, November 18, 2019 ª 2019 Th
This is an open access article under the CC BY-NC-ND license (http://formation [7–9]. Destabilization of the actin network lifts this re-
straint, enabling microtubules to engorge the tip of the neurites
and protrude toward the growth cone leading edge, a require-
ment for neurite growth [7, 10–12].
It was postulated early on that the guanosine triphosphatase
(GTPase) ras homolog gene family member A (rhoA) could con-
trol the stability of the actin network during neuron development
[13]. RhoA is thought to promote condensation of the actin
network in neurite tips acting as a negative regulator of both
axon specification and axon growth [14] and therefore having
a role in the establishment of neuronal polarity [5, 13, 15–19].
Consistently, molecular inactivation of RhoA induces supernu-
merary axons or axon growth [14, 20–23]. However, these
studies are largely based on the overexpression of mutant domi-
nant-negative (DN) and constitutively active (CA) forms of RhoA,
which also scavenge guanine nucleotide exchange factors
(GEFs) and GTPase-activating proteins (GAPs) of other Rho
GTPases [24]. In this context, it is interesting to note that RhoA
deletion in flies (Drosophilamelanogaster) or mice does not result
in obvious axon trajectory defects [25–28], as predicted by over-
expression studies [18]. Therefore, although these studies
helped to grasp the potential interactome of RhoA, the overex-
pression approach has limitations to resolve the actual physio-
logical targets [24]. Hence, the physiological role of RhoA during
neuronal polarization has remained unexplored [1, 2, 29].
The interplay of actin and microtubules in the growth cone
likely regulates axon growth [11, 30]. Studies on the giant growth
cones from stationary axons of cultured Aplysia californica bag
neurons have provided insights into neuronal actin-microtubule
interactions [10, 31, 32], which might be extendable to neurons
with fast-growing axons. A characteristic cytoskeletal feature
in these stationary growth cones are actin arcs, which are a
dense meshwork of actin filaments reminiscent of the ventral
arcs found in fibroblasts [33]. The actin motor protein myosin II
[32, 34], identified as a candidate regulator of neuron polarity
[19], generates these arcs by compacting actin filaments [10,
35]. Notably, in stationary Aplysia growth cones, actin arcs
may be controlled through RhoA [36]. Actin arcs could create a
barrier to hinder microtubule forward protrusion [31, 32, 35].
Hence, these structures have the potential to restrain axon
growth, which makes them an attractive target for regulating
axon extension. Indeed, overexpression studies showed that
RhoA could regulate axon growth and that myosin II could be a
potential target [19].e Author(s). Published by Elsevier Ltd.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Establishment of Neuronal Polar-
ity Is RhoA Independent
(A) Immunoblot of whole-brain lysates from E16.5
WT and RhoA KO embryos. Each lane represents
an independent embryo brain.
(B) Automated tile scanning showing DAPI staining
of WT and RhoA KO E17.5 brain coronal sections.
Asterisks indicate lateral ventricles (LVs). Scale
bar, 500 mm. Magnifications correspond to the
frames in the main figures. Arrowheads indicate
the ventricular surface. Scale bar, 100 mm.
(C) Automated tile scanning of WT and RhoA KO
E17.5 brain coronal sections immunolabeled with
SatB2 (red, layer II-V), Ctip-2 (magenta, layer V),
and Tbr1 (green, layer VI) antibodies. White as-
terisks indicate the cortical layers, and yellow
brackets indicate cortical plate (CP) thickness.
Marginal zone (MZ), intermediate zone (IZ), sub-
ventricular zone (SVZ), and ventricular zone (VZ)
are indicated. Scale bar, 100 mm.
(D) 3D reconstruction of automated multiphoton
tile scanning of cleared brains from WT and RhoA
KO adult mice with sparse neuronal GFP labeling.
Upper diagram indicates the imaged brain areas
(red rectangles), dentate gyrus (DG), and cornu
ammonis 1 (CA1). Scale bars, 50 mm. Magnifica-
tions show maximum intensity projections (max.
int. proj.) of the boxes in the main figures. Scale
bars, 25 mm.
(E and F) Quantification of (D). Average percentage
of neurons with single axons in the cortex (E) and
hippocampus (F) of WT and RhoA KO brains is
shown.
See also Figure S1 and Videos S1 and S2. Values
are plotted as mean ± SEM; ns, not significant by
Student’s t test. WT, N = 290; RhoA KO, N = 176
neurons from n = 7 and n = 6 cortices, respectively;
WT, N = 91; RhoA KO, N = 125 neurons from n = 4
and n = 5 hippocampi, respectively.Here, using genetic deletion experiments followed by in vivo
and cell culture analysis in combination with time-lapse and
high-resolution microscopy, we demonstrate that axon specifi-
cation is independent of RhoA. However, RhoA regulates the
onset and timing of neuronal polarization. Specifically, we
show that RhoA, by controlling microtubule protrusion into the
growth cone periphery through myosin-II-generated actin arcs,
instructs the duration of growth and pause phases that dictate
the speed of axon outgrowth.
RESULTS
RhoA Regulates Neuronal Polarization by Restraining
Axon Initiation and Growth, but Not Axon Specification
To assess the physiological function of RhoA during neuronal
polarization, i.e., axon specification, axon initiation, and axon
growth, we generated mice with conditional CNS-targeted dele-
tion of RhoA (nestin-cretg/, RhoAfl/fl; termed hereafter RhoA
KO). Immunoblot analysis showed that the RhoA protein was un-
detectable in brain extracts from embryonic day (E)16 RhoA KO
embryos (Figure 1A). RhoA KO brains had several abnormalitiescompared to brains from control littermates, including enlarged
ventricles with uneven cellular organization at their surface
(Figure 1B) accompanied by a thin cortical plate (CP) and com-
pacted lamination (Figure 1C).
To investigate the involvement of RhoA in axon specifica-
tion, we tested whether neurons in RhoA KO brains contained
supernumerary axons. To characterize the three-dimensional
morphology of RhoA KO neurons, we cleared adult brains of
RhoA KO mice that were crossed with the GFP-M mouse
line, in which neurons are sparsely labeled throughout the
brain (nestin-cretg/, RhoAfl/fl, gfp-mtg/; termed hereafter
RhoA KO[GFP]) [37, 38]. Two-photon microscopy of the
cleared cortex and hippocampus showed that RhoA KO
[GFP] neurons feature only a single axon emanating from their
cell body, as found in neurons from control WT[GFP] mice
(nestin-cre/, RhoAfl/fl, gfp-mtg/; Figures 1D–1F; Videos S1
and S2).
The possibility remained that, in the absence of RhoA, neurons
would form supernumerary axons early during development that
would be pruned at a later time point. To test this, we electropo-
rated the brains of RhoAfl/fl embryos in utero with a plasmidCurrent Biology 29, 3874–3886, November 18, 2019 3875
Figure 2. Neuron-Specific RhoA Deletion
In Vivo Accelerates Neuronal Polarization
(A) Scheme illustrating the plasmid pairs used for
in utero and ex utero electroporations. GFP is
ZsGreen (A and B; Figure S2A) or Lyn-NeonGreen
(D and E).
(B) Automated confocal tile scanning of coronal
sections from E14.5RhoAfl/fl brains electroporated
in utero at E12.5. Grey and black arrows indicate
axons from WT and RhoA KO neurons, respec-
tively. Scale bar, 200 mm.
(C) Quantification of (B). Upper diagram depicts
the analysis. The gray (WT) and black (RhoA KO)
curves represent the average density of axons
extending from the electroporated region (ER). The
bar plot indicates the average axonal density over
distance from the ER. Each dot represents the
average of two consecutive slices from a single
brain. Values are plotted as mean ± SEM; **p <
0.01 by a customized ANOVA test (F-test). WT;
N = 14 and RhoA KO; N = 15 sections from n = 7
electroporated brains each.
(D and E) Representative time-lapse images of
GFP positive WT (D) and RhoA KO (E) cortical
neurons in cultured coronal sections from brains
electroporated at E13.5. Asterisks indicate the
beginning of the bipolar (BP) stage and arrow-
heads the emergent trailing process (nascent
axon, arrowheads). Scale bars, 25 mm.
(F) Quantifications of (D) and (E). The duration of
the MP-BP transition for WT and RhoA KO
neurons is plotted as mean ± SEM; **p < 0.01
by Student’s t test. WT, N = 222 neurons and
RhoA KO, N = 317 neurons from n = 5 independent
electroporated brains each.
See also Figures S1 and S2A and Video S3.encoding Cre recombinase under the control of the neuron-spe-
cific tubulin-alpha-1 promoter (pTa1-Cre) together with a loxP
GFP (Zoanthus sp. (Zs)Green)-based recombination reporter
plasmid (Figure 2A). Thereby, recombination only occurs in neu-
rons. Hence, the generated RhoA KO neurons develop in a wild-
type (WT)-like environment. As a control, we electroporated a
plasmid encoding Dre integrase driven by the same Ta1 pro-
moter (pTa1-Dre) together with a roxP GFP (ZsGreen)-based re-
porter plasmid, leading to MOCK recombination (Figure 2A). Cre
recombinase-mediated deletion of RhoA by electroporation at
E13.5 led to more rapid neuronal migration (Figures S1A and
S1B), confirming previous results [28], and the near absence of
RhoA in biochemical extracts of RhoAfl/fl cortical neurons within
1 day in vitro (DIV) (Figure S1C). Importantly, neuronal polariza-
tion was not affected. RhoA KO and WT neurons in the CP of
E15.5 electroporated brains displayed a typical polarized bipolar
(BP) morphology (83.3% ± 1.1% versus 85.1% ± 2.1%, respec-
tively; p = 0.52; Figure S1D) characterized by one leading pro-
cess and a single trailing process, which will later become the
axon (Figure S1E) [39]. Hence, axon specification is independent
of RhoA.3876 Current Biology 29, 3874–3886, November 18, 2019Next, we investigated the role of RhoA
in axon initiation and growth. To analyze
early axon formation in vivo, we electro-
porated RhoAfl/fl embryos at E12.5, al-lowing axons from recombined neurons to elongate as pioneer
axons [3], and analyzed their trajectories at E14.5. Although
axons from both RhoA KO and control neurons emerged within
the CP and intermediate zone (IZ) (Figures 2B and 2C), RhoA
KO axons covered longer distances than control axons (Fig-
ures 2C and S2A). To assess the dynamics of initial axon
outgrowth, we prepared organotypic slice cultures from
E13.5 ex utero electroporated (EUE) embryos and performed
live-cell imaging 1 day later. RhoA KO neurons transitioned
quicker from the multipolar (MP) to the bipolar (BP) stage and
developed their single axon faster than WT neurons (14.1 h ±
0.4 h versus 18.6 h ± 0.9 h, respectively; p < 0.01; Figures
2D–2F; Video S3).
Dissociated RhoA KO hippocampal neurons recapitulated the
in vivo phenotype and showed a more rapid polarization (Figures
3A and 3B). As early as 12 h after plating, more than twice as
many RhoA KO neurons contained an axon positive for the
axonal marker Tau-1 compared to WT control neurons (Fig-
ure 3C; 39.5% ± 4.3% versus 16.9% ± 4.5%, respectively; p <
0.0001). Axons of RhoA KO neurons were also longer than those
generated by WT neurons (Figure 3D). At later time points, WT
Figure 3. RhoA Restrains Neuronal Polari-
zation and Axon Growth
(A) Scheme illustrating the development of
cultured pyramidal neurons.
(B) Representative fluorescence images of disso-
ciated E17.5 WT and RhoA KO hippocampal
neurons cultured for 12 h with or without C3T
treatment. Immunolabeling for bIII tubulin (Tuj, red)
and Tau-1 (green) is shown. Arrowheads indicate
Tau-1-positive axons. Scale bar, 50 mm.
(C and D) Quantification of (B).
(C) Average percentage of neurons in stages 1–3.
(D) Average total length of Tau-1-positive axons.
WT, N = 266; RhoA KO, N = 306; WT+C3T,
N = 321; and RhoA KO+C3T, N = 286 neurons from
n = 4 independent experiments.
(E and F) Morphological assessment of dissoci-
ated hippocampal neurons cultured 48 h in the
same conditions as in (B).
(E) Average percentage of neurons in stages 1–3.
(F) Average total length of Tau-1-positive axons.
WT, N = 439; RhoA KO, N = 316; WT+C3T,
N = 376; and RhoA KO+C3T, N = 335 neurons from
n = 4 independent experiments.
(G) Representative fluorescence images of disso-
ciated E17.5 hippocampal neurons electroporated
with a mix of GFP-expressing reporter plasmids
plus either scrambled RNAi (scramRNAi), RhoA
RNAi-1, or RhoA RNAi-2 and cultured for 24 h.
Immunolabeling for bIII tubulin (Tuj, blue) and
Tau-1 (red) is shown. Arrowheads indicate Tau-1-
positive axons. Scale bar, 50 mm.
(H) Quantification of (G). Average total length of
Tau-positive axons is shown. scramRNAi, N = 139;
RhoA-RNAi-1, N = 119; and RhoA-RNAi-2, N = 143
neurons from n = 3 independent experiments.
(I) Representative fluorescence images of 48-h
cultures of dissociated E17.5 hippocampal neu-
rons electroporated and immunolabeled as in (G).
Arrowheads indicate Tau-1-positive axons. Scale
bar, 50 mm.
(J) Quantification of (I). Average total length of Tau-
positive axons is shown. scramRNAi, N = 115;
RhoA-RNAi-1, N = 121; and RhoA-RNAi-2, N = 94
neurons from n = 3 independent experiments.
(K) Representative fluorescence images of
48-h cultures of WT and RhoA KO hippo-
campal neurons expressing GFP (left and
middle, respectively) and RhoA KO hippo-
campal neurons expressing GFP-hRhoA (right).
Immunolabeling for bIII tubulin (Tuj, blue) and Tau-1 (red) is shown. Arrowheads indicate Tau-1-positive axons. Scale bar, 50 mm.
(L) Quantification of (K). Average total length of Tau-positive axons is shown. WT+GFP, N = 140; RhoA KO+GFP, N = 121; and RhoA KO+GFP-hRhoA, N = 95
neurons from n = 3 independent experiments.
See also Figures S2G, S2H, and S3A–S3D. Values are plotted as mean ± SEM (C and E) or mean + SEM (D, F, H, J, and L). Statistical significance: ***p < 0.001;
**p < 0.01; *p < 0.05; ns, not significant by ordinal logistic regression (C and E; see Statistical Analysis section), by generalized linear model test (D and F; see
Statistical Analysis section), and by one-way ANOVA followed by Tukey’s post-test (H, J, and L).neurons also formed an axon (Figure 3E), but axons of RhoA KO
neurons continued to be substantially longer (Figure 3F). Inter-
estingly, in RhoA KO neurons, the onset of spontaneous excit-
atory postsynaptic currents (sEPSCs) was detected earlier
compared to WT neurons, suggesting an acceleration of synap-
tic maturation. Already at 4 DIV, 13.3% (4 out of 30) of RhoA KO
neurons showed sEPSCs, which were not detected in WT
neurons (0 out of 29; Figures S2B and S2C). After 7 DIV, 85%
(17 out of 20) of cultured RhoA KO neurons showed sEPSCscompared to only 38.9% (7 out of 18) of WT neurons (Figures
S2B and S2C). Moreover, RhoA KO neurons showed a higher
frequency of sEPSCs than WT neurons (RhoA KO, 2.2 ± 0.8 Hz
versus WT, 0.2 ± 0.1 Hz; p < 0.001; Figure S2D), while the ampli-
tudes of the sEPSCs were similar between WT and RhoA KO
neurons (96.2 ± 30.5 pA versus RhoA KO, 81.4 ± 10.3 pA,
respectively; p = 0.74; Figure S2E).
Acute downregulation of RhoA by two independent RNAi
probes mirrored the RhoA KO phenotype (Figures 3G–3J andCurrent Biology 29, 3874–3886, November 18, 2019 3877
S2F). Re-expression of RhoA in RhoA KO neurons restored a
shorter axon equal to WT neurons (Figures 3K and 3L). Consis-
tent with our in vivo results, we did not observe differences in
the number of neurons bearing multiple axons between WT
and RhoA KO cultures (2.9% ± 1.3% versus 4.0% ± 1.0%,
respectively; p = 0.52; Figure S2G). Interestingly, WT neurons
treated with C3 exoenzyme, which inactivates all RhoA,
RhoB, and RhoC [40], showed a growth pattern indistinguish-
able from RhoA KO neurons, suggesting a prominent role for
RhoA at this stage of axon development (Figures 3B–3F).
Notably, additional inactivation of RhoB and RhoC by C3
exoenzyme in RhoA KO neurons did not increase the number
of neurons containing multiple axons (RhoA KO versus RhoA
KO+C3T; 4.0% ± 1.0% versus 6.5% ± 1.3%, respectively;
p = 0.09; Figure S2G) or affect axon length (Figures 3B–3F).
Similarly, downregulation of RhoB by an RNAi approach in
RhoA KO neurons (Figure S3A) neither enhances axon growth
further (Figures S3B and S3C) nor generates additional neu-
rons with supernumerary axons (Figure S3D) compared to
RhoA KO neurons. Thus, although RhoA is not involved in
axon specification, it restrains the onset and rate of neuronal
polarization.
Non-muscular Myosin II Is a Physiological Target of
RhoA during Neuronal Polarization
To determine the physiologically relevant effectors downstream
of RhoA that restrain axon growth, we first assessed RhoA
crosstalk with other related Rho-GTPases. Cdc42 and Rac1
are known promoters of axon growth whose genetic ablation
severely impairs axon outgrowth [41, 42]. We examined the pro-
tein level and activation state of Cdc42 and Rac1 in biochemical
extracts of cultured cortical RhoA KO neurons and found them to
be similar to WT neurons (Figures S3E–S3G). RhoA activates
Rho-associated, coiled-coil-containing protein kinase (ROCK)
as its immediate downstream target [43] (Figure 4A). Consis-
tently, in biochemical extracts from cultured cortical RhoA KO
neurons, ROCK activity decreased compared to WT extracts
(Figure 4B). Overexpression studies in cell lines have previously
shown that activated ROCK phosphorylates LIM domain kinase
(LIMK) [44, 45], which in turn regulates cofilin activity [46, 47] (Fig-
ure 4A). Moreover, cofilin drives neurite formation [48] and axon
regeneration in the CNS [49]. However, immunoblot analysis of
extracts from cortical neuronal cultures revealed no difference
in the level of phosphorylated (p)-LIMK or of p-cofilin between
WT and RhoA KO neurons (Figures 4C–4F). Immunocytochem-
istry confirmed that the p-cofilin/cofilin ratio in the growth cone
was similar between WT and RhoA KO hippocampal neurons
(Figures 4G and 4H), further suggesting that RhoA does not regu-
late axon growth through cofilin.
ROCK also activates myosin II by directly phosphorylating its
regulatory myosin light chain (MLC2) and also indirectly by phos-
phorylation of the regulatory myosin phosphatase target sub-
unit-1 (MYPT-1) of the myosin phosphatase [50, 51] (Figure 4A).
Indeed, immunoblot analysis of cultured cortical neuronal ex-
tracts and immunocytochemistry showed that both p-MYPT-1
and p-MLC2 levels decreased in RhoA KO compared to WT hip-
pocampal neurons (Figures 4I–4N). Hence, myosin-II-actin-
mediated restraint could be a potential physiological regulator
of axon growth downstream of RhoA.3878 Current Biology 29, 3874–3886, November 18, 2019Myosin II Restrains Axon Growth Downstream of RhoA
Inactivation of myosin II in hippocampal WT neurons by using
20 mM blebbistatin (Blebb) leads to the generation of supernu-
merary axons (Figure S3H), consistent with previous reports
[23, 52]. As myosin II was only partially inactivated in RhoA KO
neurons, we askedwhether amoderate decrease inmyosin II ac-
tivity could recapitulate the RhoA KO phenotype by enhancing
onset and rate of neuronal polarization without perturbing axon
specification. WT hippocampal neurons treated with 0.5 mM
Blebb fully recapitulated the phenotype of RhoA KO neurons at
all observed time points (Figures 5A–5E and S3I). Already at
12 h, Blebb-treated cultures showed a higher proportion of stage
3 neurons and longer axons compared to control WT neurons
(Figures 5A–5C). Moreover, at later time points, Blebb-treated
neurons had extended a long axon without forming supernumer-
ary axons, preserving neuronal polarity (Figures 5D, 5E, and S3I).
Time-lapse microscopy revealed that axons of hippocampal
RhoA KO neurons and Blebb-treated WT neurons grew not
only faster than axons from vehicle-treated WT neurons (Figures
5F and 5G; Video S4) but also paused for shorter periods of time
(1.67 h ± 0.06 h and 1.48 h ± 0.12 h versus 2.07 h ± 0.09 h,
respectively; p < 0.01; Figures 5H and S3J). Conversely, overex-
pression of a phospho-mimetic (T18D; S19D) constitutively
active MLC2 mutant (MLC2-CA) in RhoA KO neurons abolished
their characteristic early-polarity onset and drastically reduced
axonal growth (Figures S5A–S5F).
We asked next whether the growth enhancement found after
myosin II inhibition could be recapitulated by actin destabiliza-
tion. Indeed, similar to myosin II inhibition, destabilizing the actin
cytoskeleton with high latrunculin A (Lat A) doses (25 nM) led to
the formation of supernumerary axons (Figures S3H and S4A),
while modest Lat A doses (5 nM) accelerated the onset of axon
initiation and enhanced the growth of a single axon, hence main-
taining polarity (Figures S4A–S4D). Thus, mild actin instability
caused by partial inhibition of myosin II activity drives the
enhanced axon growth of developing RhoA KO neurons.
RhoA Drives Actin Arc Formation in the Growth Cone
through Myosin II
As the machinery for axon growth is thought to be located in its
growth cone, we characterized the growth cone cytoskeleton in
RhoA KO neurons. Phalloidin staining of fixed co-cultures of WT
and RhoA KO hippocampal neurons (Figure S6A) revealed a
comparable amount and a similar distribution of polymerized
fibrous (F)-actin between WT and RhoA KO neurons (Figure 6A).
The balance between soluble globular (G) actin and F-actin has
previously been proposed to be an indicator of gross changes
in growth cone cytoskeleton dynamics and axon growth [48].
An equal G/F-actin ratio was found between biochemical ex-
tracts from WT and RhoA KO neuronal cultures (Figures 6B
and 6C). Importantly, however, stimulated emission depletion
(STED) microscopy revealed structural differences in growth
cone actin architectures. Although the majority (83.3% ± 0.9%)
of WT neurons contained actin arcs in their axonal growth
cone, these structures were present in few RhoA KO growth
cones (23.2%± 0.5%; p < 0.0001; Figures 6D and 6E). Moreover,
F-actin bundles in WT growth cones were prominent at the pe-
ripheral (P)-domain of the growth cone and terminated within
the actin arc structures at the transition (T)-domain. In RhoA
Figure 4. RhoA Regulates Cytoskeleton Or-
ganization and Dynamics through Myosin II
and Independent of Cofilin
(A) Schematic of RhoA canonical signaling and its
effects on actin structures.
(B) Quantification of ROCK activity in cultured
neurons. WT, N = 5 and RhoA KO, N = 6 lysates
from n = 3 independent experiments.
(C) Immunoblot showing protein levels for phos-
pho(p)-LIMK and total LIMK in cell lysates from
cultured WT and RhoA KO neurons.
(D) Quantification of (C). WT, N = 4 and RhoA KO,
N = 4 lysates from n = 4 independent experiments.
(E) Immunoblot showing protein levels for phos-
pho(p)-cofilin and total cofilin in cell lysates from
cultured WT and RhoA KO neurons.
(F) Quantification of (E). WT, N = 4 and RhoA KO,
N = 4 lysates from n = 4 independent experiments.
(G) Representative fluorescence images of 24-h
cultures of WT (upper row) and RhoA KO (lower
row) neurons immunolabeled for total cofilin (red)
and p-cofilin (green). Scale bars, 25 mm. Magnified
insets show the axonal growth cone. Scale bars,
5 mm.
(H) Quantification of (G). WT, N = 37 and RhoA KO,
N = 41 axonal growth cones from n = 4 indepen-
dent experiments.
(I) Immunoblot showing protein levels for phos-
pho(p)-MYPT1 and total MYPT1 in cell lysates from
cultured WT and RhoA KO neurons.
(J) Quantification of (I). WT, N = 3 and RhoA KO,
N = 3 from n = 3 independent experiments.
(K) Immunoblot showing protein levels for phos-
pho(p)-MLC2 and total MLC2 in cell lysates from
cultured WT and RhoA KO neurons.
(L) Quantification of (K). WT, N = 5 and RhoA KO,
N = 5 from n = 5 independent experiments.
(M) Representative fluorescence images of 24-h
cultures of WT (upper row) and RhoA KO (lower
row) neurons immunolabeled for total MLC2 (red)
and p-MLC2 (green). Scale bar represents 25 mm.
Magnified insets show the axonal growth cone.
Scale bar, 5 mm.
(N) Quantification of (M). WT, N = 40 and RhoA KO,
N = 39 axonal growth cones from n = 4 indepen-
dent experiments.
See also Figures S3E–S3G. All values are plotted
as mean + SEM. Statistical significance: ***p <
0.001; **p < 0.01; *p < 0.05; ns, not significant by
Student’s t test.KO growth cones, by contrast, F-actin bundles were longer and
many spanned from the leading edge to the base of the growth
cone (Figures 6D and 6F).
Pharmacological myosin II inactivation reproduced the RhoA
KO growth cone morphology. WT hippocampal neurons treated
with 0.5 mM Blebb lacked actin arcs in their growth cones
(30.8% ± 0.9% versus 83.3% ± 0.9% for Blebb versus WT,
respectively; p < 0.01), similar to the decrease detected in
growth cones of RhoA KO neurons (Figures 6D and 6E). More-
over, the F-actin bundles of Blebb-treated WT growth cones
were longer compared to the F-actin bundles of WT growth
cones but similar to those of RhoA KO growth cones (Figures
6D and 6F). Conversely, overexpression of constitutively activeform (MLC2-CA) in RhoA KO neurons restored actin arc forma-
tion to WT-like levels (Figures S5G and S5H). Thus, RhoA gener-
ates actin arcs in the growth cone through myosin II.
Myosin-II-Generated Actin Arcs Downstream of RhoA
Impede Axon Growth by Restraining Microtubule
Protrusion
In growth cones of mouse pyramidal neurons (Figure S6B), actin
retrograde flow speed decreases at the T-domain, relative to the
P-domain, as actin filaments become compressed against the
actin arcs, recapitulating processes of stationary Aplysia growth
cones [10]. Given the loss of actin arcs and the extension of
F-actin bundles into the central (C)-domain in RhoA KO growthCurrent Biology 29, 3874–3886, November 18, 2019 3879
Figure 5. Partial Myosin II Inhibition Reca-
pitulates the Accelerated Onset of Polarity
and Enhanced Axonal Growth of RhoA KO
Neurons
(A) Representative fluorescence images of disso-
ciated E17.5 hippocampal WT, RhoA KO, and
0.5 mM-Blebb-treated WT neurons after 12 h in
culture. Immunolabeling for bIII tubulin (Tuj, red)
and Tau-1 (green) is shown. Arrowheads indicate
Tau-1-positive axons. Scale bar, 50 mm.
(B and C) Quantification of (A).
(B) Average percentage of neurons in stages 1–3.
(C) Average total length of Tau-1-positive axons.
WT,N=278;RhoAKO,N=281;andWT+Blebb,N=
271 neurons from n = 3 independent experiments.
(D and E) Morphological assessment of dissoci-
ated hippocampal neurons cultured 48 h in the
same conditions as in (A).
(D) Average percentage of neurons in stages 1–3.
(E) Average total length of Tau-1-positive axons.
WT,N=159;RhoAKO,N=157;andWT+Blebb,N=
136 neurons from n = 3 independent experiments.
(F) Representative bright-field micrographs from a
20-h time-lapse video microscopy of WT (upper
row), RhoA KO (middle row), and 0.5 mM-Blebb-
treated (bottom row) neurons growing in culture.
White arrowheads indicate the axon. Scale bar,
25 mm.
(G) Average axon elongation (primary shaft) over
time for the neurons in (F). WT, N = 32; RhoA KO,
N = 40; and WT+Blebb, N = 23 neurons from n = 4
independent experiments.
(H) Average cumulative duration of axon pause
events for the neurons in (G). The number of cells
analyzed is the same as in (G).
See also Figures S3H–S3J, S4A–S4D, and S5 and
Video S4. Values are plotted asmean ± SEM (B, D,
and G) or mean + SEM (C, E, and H). Statistical
significance: ***p < 0.001; **p < 0.01; *p < 0.05; ns,
not significant by ordinal logistic regression (B and
D; see Statistical Analysis section), by generalized
linear model test (C and E; see Statistical Analysis
section), and by one-way ANOVA followed by
Tukey’s post-test (G and H).cones, we hypothesized that centripetal movement of actin fila-
mentsmight therefore be unrestricted and turnover more rapidly.
Indeed, time-lapse imaging of actin dynamics in growth cones
from hippocampal RhoA KO neurons transfected with Lifeact
[53] (Figure 7A) showed increased retrograde flow compared
to WT growth cones (Figure 7B). Myosin II inactivation recapitu-
lated the RhoA KO phenotype: actin retrograde flow in the
P-domain of the growth cone was enhanced in Blebb-treated
WT neurons, reaching speeds comparable to RhoA KO neurons
(Figure 7B). Moreover, the speed of actin retrograde flow in the
T-domain of growth cones of RhoA KO neurons was significantly
higher than the actin retrograde flow measured in WT neurons
but similar to Blebb-treated WT neurons (6.02 ± 0.14 mm/min
versus 5.92 ± 0.12 mm/min versus 5.52 ± 0.12 mm/min, respec-
tively; WT versus RhoA KO p < 0.05; WT versus Blebb p <
0.05; RhoA KO versus Blebb p = 0.59; Figure 7B, right). This
finding raises the possibility that increased actin retrograde
flow in the growth cone T-domain reflects the disassembly of
the actin arc barrier, whichmight lead to a less-efficient retention
of microtubules in the C-domain.3880 Current Biology 29, 3874–3886, November 18, 2019We therefore studied microtubule advance in neurons ex-
pressing end-binding protein 3 (EB-3), a marker of polymerizing
microtubule ends, fused to mCherry [48, 54] (Figure 7C). In both
RhoA KO and Blebb-treated WT growth cones, we found that
microtubule advance speed in the P-domain was higher
compared to WT growth cones (Figure 7D). As a result, microtu-
bules reached closer to the leading edge of RhoA KO and
Blebb-treated WT growth cones compared to vehicle-treated
WT growth cones (Figures 6D, 7C, and 7E; Video S5). Similarly,
growth cones of fast-elongating Lat-A-treated axons showed
a disorganized actin network without actin arcs (Figures
S4E–S4G). This, in turn, led microtubules to reach closer to
the growth cone leading edge compared to the microtubules
in vehicle-treated growth cones (Figures S4E and S4H–S4J).
These findings further support the hypothesis that RhoA im-
pedes axon growth by restraining microtubule protrusion into
the P-domain of the growth cone. To test this hypothesis directly,
we deduced that moderate microtubule destabilization should
reverse the enhanced axon growth observed in RhoA KO neu-
rons. Indeed, cultured RhoA KO neurons with low doses of the
Figure 6. Partial Myosin II Inhibition in WT
Neurons Leads to Actin and Microtubule
Cytoskeleton Rearrangements, which
Mimic that of RhoA KO Neurons
(A) Representative fluorescence images of dissoci-
ated WT (GFP positive) and RhoA KO E17.5 hippo-
campal neurons co-cultured for 12 h. Immunolab-
eling forbIII tubulin (Tuj, blue) andphalloidin (F-actin,
red) is shown. Scale bar, 25 mm. Magnifications
(right) feature phalloidin stainingof the growth cones
boxed in the main figure. Scale bar, 5 mm.
(B) Immunoblot shows the levels of G-actin and
F-actin in cell lysates from cultured WT and RhoA
KO neurons.
(C) Quantification of (B). WT, N = 6 and RhoA KO,
N = 5 lysates of cultured neurons from n = 3 in-
dependent experiments.
(D) Super-resolution micrographs of axonal growth
cones fromWT (upper row), RhoA KO (middle row),
and 0.5-mM-Blebb-treated (bottom row) neurons.
Immunolabeling for bIII tubulin (Tuj, red) and phal-
loidin (F-actin, green) is shown. Red arrows indicate
actin arc-rich T-domain and red arrowheadsF-actin
bundles.Microtubules in thegrowthconeP-domain
are indicated by blue asterisks, bundled microtu-
bules by blue arrowheads, and microtubules re-
tained in the C-domain by blue arrows. Scale bars,
5 mm. Magnifications correspond to the frames in
themain figures. Dashed lines in themagnifications
represent the alignment of F-actin (red)with respect
to microtubules (blue). Scale bars, 2 mm.
(E) Quantification of (D). Average percentage of
axonal growth cones featuring actin arcs is shown.
WT, N = 48; RhoA KO, N = 56; and WT+Blebb, N =
52 growth cones from n = 5 independent experi-
ments.
(F) Quantification of (D). Average length of F-actin
bundles in axonal growth cones is shown. WT, N =
38;RhoAKO,N=42; andWT+Blebb, N=31growth
cones from n = 4 independent experiments.
See also Figures S4E–S4H, S5G–S5H, S6A, and
S7A and Videos S5 and S6. Values are plotted as
mean±SEM (CandE) ormean+SEM (F). Statistical
significance: ***p < 0.001; **p < 0.01; *p < 0.05; ns,
not significant by Student’s t test (C) and one-way
ANOVA followed by Tukey’s post-test (E and F).microtubule-destabilizing drug nocodazole (50 nM) decreased
their axonal lengths to measurements found in WT control
neurons (Figures 7F and 7G). Hence, modest microtubule desta-
bilization in RhoA KO neurons restores WT-like neuronal
morphology. Thus, RhoA restrains axon growth by confining
microtubules to the central growth cone domain through
myosin-II-generated actin arcs (Figure S7A).
DISCUSSION
Polarization is a hallmark of neuronal development. It involves
the specification of the future axon from several minor neurites
and the execution of a growth program in the specified neurite
through accelerated growth. Here, we demonstrate that RhoA
is not required for axon specification, but it decelerates neuronal
polarization in the developing mammalian brain. RhoA restrains
neuronal polarization and axon growth by inducing myosin-II-generated actin arcs to prevent microtubule protrusion in the
axonal growth cone. We will discuss in detail how these findings
change our perspective on neuronal polarization.
The Physiological Role of RhoA during Neuronal
Polarization
The Rho-GTPases Cdc42 and Rac1 cause actin rearrangements
that favor neurite outgrowth and axon formation [9, 41, 42, 55],
whereas high RhoA activity was thought to prevent minor neu-
rites from becoming axons [1, 5, 16, 56, 57]. Strikingly, our
data demonstrate that RhoA is not involved in axon specification.
RhoA KO neurons achieved the prototypical polarized architec-
ture: they contained a single axon and multiple dendrites both in
culture and in vivo during development, as well as in the adult
brain. Instead, RhoA is involved in the onset and timing of
neuronal polarity. Our analyses of RhoA KO neurons in the devel-
oping brain as well as in cell culture pinpoints RhoA as aCurrent Biology 29, 3874–3886, November 18, 2019 3881
Figure 7. Partial Myosin II Inhibition Is Suffi-
cient to Reproduce the Dynamics of RhoA
KO Neurons
(A) Representative construction of kymographs
from axonal growth cones of E17.5 hippocampal
neurons expressing Lifeact-GFP. Line scans used
to create the kymographs are shown in red. Black
arrows correspond with actin retrograde flow
speed. Scale bars, 5 mm.
(B) Average speed of actin retrograde flow in the
P-domain (left) and T-domain (right) in axonal
growth cones. WT, N = 29; RhoA KO, N = 39; and
WT+Blebb, N = 29 axonal growth cones from n = 3
independent experiments.
(C) Maximum intensity projection (max. int. proj.) of
time-lapse image series taken from axonal growth
cones from hippocampal neurons expressing
EB3-mCherry in the different conditions. Arrow-
heads indicate microtubules that reached the
leading edge (red dashed line). Scale bar, 5 mm.
(D) Average advance speed of EB3-mCherry
comets. WT, N = 24; RhoA KO, N = 24; and
WT+Blebb, N = 26 axonal growth cones from n = 3
independent experiments.
(E) Average percentage intensity of EB3-mCherry
signal with respect to the growth cone leading
edge. WT, N = 28; RhoA KO, N = 37; and
WT+Blebb, N = 29 axonal growth cones from n = 3
independent experiments.
(F) Representative fluorescence images of dissoci-
ated E17.5 hippocampal neurons after 12 and 48 h
in culture. From top to bottom: WT, RhoA KO, and
RhoA KO plus nocodazole treatment is shown.
Immunolabeling for bIII tubulin (Tuj, red) and Tau-1
(green) is shown. Arrowheads indicate axons. Scale
bar, 50 mm.
(G) Quantification of (F). Average total length of tau-
positive axons. 12 h: WT, N = 373; RhoA KO,
N = 425; and RhoA KO+nocodazole, N = 351; 48 h:
WT, N = 321; RhoA KO, N = 303; and RhoA
KO+nocodazole, N = 312 neurons from n = 4 inde-
pendent experiments.
See also Figures S4I, S4J, S6B, and S7A and
Videos S5 and S6. Values are plotted as mean ±
SEM (B and E) or mean + SEM (D and G). Statistical
analysis: ***p < 0.001; **p < 0.01; *p < 0.05; ns, not
significant by one-way ANOVA followed by New-
man-Keuls post-test (B), by paired Student’s t test
(central versus peripheral for each condition, black),
by one-way ANOVA followed by Tukey’s post-test
(peripheral among conditions, red; D), by two-way
ANOVA followed by Tukey’s post-test (E), and by
one-way ANOVA followed by Tukey’s post-test (G).physiological growth brake that limits axon initiation and enables
axon growth pauses. Axons have previously been observed to
grow in spurts interrupted by pausing events [4, 58], which are
less frequent in RhoA KO neurons. The periodic axon growth
mediated by the RhoA-controlled growth brake could facilitate
synchronization of axon elongation with the supply of building
blocks necessary for growth. Moreover, as a premature arrival
of axons would be disruptive for neuronal circuitry [59], slowing
down axon growth may help the brain to mature in a coordinated
fashion. In line with this concept, our data also indicate that RhoA
could restrain the functional maturation of axons, delaying the
onset of synaptic activity. We anticipate that decelerating axon3882 Current Biology 29, 3874–3886, November 18, 2019growth andmaturationmight play a prominent role in the nervous
system of mammals with long gestation periods, including hu-
mans, where axons grow relatively slowly [60].
Actin Arcs, the Physiological Brake to Axon Growth
Actin filaments and microtubules may generate two counteract-
ing forces to keep axon growth in balance [11, 30, 61, 62].
Whereas actin filaments can create structures in the growth
cone that halt axon elongation, protruding microtubules propel
axon growth [48, 63–65]. What are the molecular mechanisms
that allow conversion between axon growth and growth cone
arrest? Using STEDmicroscopy to investigate embryonicmouse
neurons, we detected actin arcs in the majority of WT growth
cones, which previously have mainly been associated with the
growth cones of stationary axons, such as those of Aplysia
bag neurons [10]. This was in contrast to RhoA KO neurons,
where only a few growth cones contained actin arcs, which initi-
ated and extended axons quickly. Thus, actin arcs appear to be
indicators of pausing axons.
The microtubule array in RhoA KO growth cones responded to
the reorganization of their actin cytoskeleton. Microtubules in
RhoA KO growth cones projected in bundles through a
corridor-like structure flanked by actin filaments, an organization
previously described for axons during the elongating phase [11].
Compared to microtubules in WT growth cones, microtubules in
RhoA KO growth cones experienced less hindrance through the
T-domain and, consequently, reached the growth cone’s leading
edge more frequently. The resulting faster growth of axons in
RhoA KO neurons can be reversed by modest microtubule
destabilization. Thus, RhoA regulates axon growth by controlling
microtubule protrusion through the gating activity of actin arcs in
the growth cone.
Myosin II, the Physiological Instructor of Actin Arcs
Downstream of RhoA Restraining Axon Growth
Various signaling pathways and effector molecules downstream
of RhoA were discussed as candidate regulators of neuronal po-
larity, including profilins, formins, ADF/cofilin, and myosins [2, 5,
17, 30, 66]. Our work demonstrates that genetic inactivation of
RhoA leaves the G/F-actin ratio intact while leading to a partial
inhibition of myosin II. This causes a decrease in actin arc forma-
tion along with microtubule protrusion to the axonal growth cone
leading edge and accelerated axon growth without affecting
axon specification. The partial inhibition of myosin II in RhoA
KO neurons is likely due to its multiple sources of activation
and deactivation, some of which are RhoA dependent, including
ROCK and MYPT-1, whereas others are RhoA independent,
including the myosin light chain kinase (MLCK) [67]. In fact, the
RhoA KO phenotype is fully recapitulated by low doses of Blebb
treatment. It argues that RhoA is less promiscuous during
neuronal polarization than previously thought, revealing myosin
II as the central physiologically relevant target.
Of note, the pool of inactivated myosin in neurons includes the
highly expressed myosin IIB isoform and also myosin IIA, which
is present at lower levels [19, 68, 69]. Myosin IIB and IIA differ in
their kinetic properties, but they show overlapping functions [68]
and undergo isoform-specific reorganizations in the axonal
growth cone, depending on their growth substrates [35]. Given
its expression levels in developing neurons, myosin IIB is likely
to be a more relevant target effector for RhoA than myosin IIA.
In this line, similar to RhoA ablation, deletion of myosin IIB or
its replacement for a motor-impaired myosin IIB mutant during
embryonic development leads to the destabilization of adherens
junctions in the ventricular surface, resulting in the enlargement
of the cerebral ventricles (hydrocephalus) [68, 69]. Future studies
will decipher the specific contributions of these myosin isoforms
to the regulation of neuron polarity.
In polarizing neurons, the actin network in the nascent axon is
more susceptible to destabilization than that of future dendrites,
an imbalance required to single out a fast-elongating axon [7].
Our data suggest that partial inhibition of myosin II or milddestabilization of the actin network, both contributing to relax
the actomyosin system, leave the polarity program intact while
facilitating its execution through early onset of axon formation
and enhanced axon elongation. On the contrary, strong destabi-
lization of the actomyosin system, by high doses of the myosin II
inhibiting agent Blebb as well as actin-depolymerizing drugs,
simply overrides the polarity program enabling multiple neurites
to become axons [7–9, 23, 52]. It is interesting to consider the
possibility that, besides its role as gatekeeper at the T-domain
of axonal growth cones, the actomyosin system could also act
globally as an intracellular corset that guides intrinsic neuronal
polarization. Consistent with this view, the RhoA-dependent
actomyosin cortical network is required to initiate membrane ex-
tensions during polarized growth in endothelial cells and in tu-
mor-derived cell lines [70–72]. Thus, molecular manipulations
that only relax but do not demolish the actin-myosin network
would favor axon growth but still preserve polarity.
Conclusions
Multiple candidate molecules with promising instructive roles in
early axon development have been identified. It has remained
challenging, however, to unambiguously distinguish between
molecules with essential roles in axon specification and those
required only to regulate axon growth [73]. Here, we show that
the physiological role of RhoA in neuronal polarization is to
restrain the onset and the rate of axon growth, but not to specify
the axon. RhoA functions by activating myosin II, which enables
compaction of actin filaments to form actin arcs in the T-zone of
the growth cone. These actin arcs restrain microtubule protru-
sion and, consequently, axon growth. Thus, this work defines a
physiologically relevant molecular brake of axon growth during
development.
It is noteworthy that the last two decades have seen enormous
efforts to exploit the RhoA/ROCK pathway as a therapeutic tool
to alleviate pathological and traumatic CNS conditions by
inducing axon regeneration [74–76]. Given that axon regenera-
tion is hypothesized to be a recapitulation of developmental pro-
cesses [77] and that the cytoskeleton plays a key role during
axon regeneration [64, 78, 79], this work has laid a promising ba-
sis to better understand the molecular mechanisms that could
lead to axon regeneration.
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Dr. Manuel Scholling, Image and
Data Analysis Facility, DZNE Bonn
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DeltaVision RT Applied Precision N/A
Microscope Axio Observer D1 ZEISS 590636
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Decloaking ChamberTM NxGEN Biocare DC2012-220V
35 mm Dish, No. 1.5 Coverslip, 14 mm Glass Diameter,
Uncoated
MatTek P35G-1.5-14-C
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DIGIDATA 1550B; electrophys data acquisition system Molecular Devices DIGIDATA1550LEAD CONTACT AND MATERIALS AVAILABILITY
The plasmids generated in this study have been deposited to Addgene (see Table S2). Further information and requests for resources
and reagents should be directed to and will be fulfilled by the Lead Contact, Frank Bradke (frank.bradke@dzne.de). There are no re-
strictions on any data or materials presented in this paper.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
All animal experiments were performed in accordance with the Animal Welfare Act and the guidelines of the North Rhine-Westphalia
State Environment Agency (Landesamt fu¨r Natur, Umwelt und Verbraucherschutz (LANUV)). The animals were group housed (up to
5mice per cage) with room temperature controlled at 21–22C, and an artificial 12-h light:dark cycle (lights off at 6:00 pm). Mice were
given food and water ad libitum throughout the experiment.
Transgenic Mice
CNS conditional RhoA KO mice
To obtain RhoA ablation in the nervous system we used a mouse line, with exon 3 of the RhoA gene flanked by loxP sites, referred to
as RhoAfl/fl [80]. To obtain mouse embryos with a CNS conditional ablation of RhoA, RhoAfl/flmice were first mated with a transgenicCurrent Biology 29, 3874–3886.e1–e9, November 18, 2019 e3
Nestin-Cre driver line [81] to generate nes-cretg/-, RhoAfl/wt mice that were subsequently crossed with homozygous RhoAfl/fl mice.
The mating yielded embryos with genotypes in the expected Mendelian ratios including nes-cretg/-, RhoAfl/fl, here on referred as
RhoA KO, and nes-cre/, RhoAfl/fl control littermates here on referred as WT. To obtain sparse GFP neuronal labeling in adult
RhoA KO mice, we first generate RhoAfl/fl,gfp-mtg/tg mice by mating RhoAfl/fl and gfp-mtg/tg [82] to obtain a RhoAfl/wt,gfp-mtg/- F1.
F1 mice were then inter-crossed until obtaining progeny that showed homozygosity for both transgenes. These mice were then
crossed with nes-cretg/-,RhoAfl/wt mice to obtain RhoA KO[GFP] (nes-cretg/-,RhoAfl/fl;gfp-mtg/-) and WT[GFP] (nes-cre/,RhoAfl/
fl;gfp-mtg/-) mice. Mice ubiquitously expressing enhanced green fluorescent protein (EGFP)-mice under a ‘‘CAG’’ promoter [83]
were from the Jackson laboratory. All mice were kept on a C57BL/6J background.
METHOD DETAILS
Neuronal Cell Culture
Cell Culture
Primary hippocampal neurons were obtained from embryonic day 16.5 (E16.5) to E17.5 mouse embryos. Glia-free cultures were per-
formed similarly to as previously described [84]. In brief, after dissection, hippocampi were collected in HBSS (Thermo Fisher). For
RhoA KO cultures, we followed the same procedure but processing the hippocampi from individual embryos separately to maintain
genetic identity of the subsequent cultures. Next, hippocampi were digested in trypsin 0.05% (Thermo Fisher) for 15 min and the re-
action was stopped by addition of MEM-horse serum (MEM-HS) media [1X MEM, 1X essential and non-essential amino acids, 2mM
L-glutamine (all from Thermo Fisher), 0.22% NaHCO3, 0.6% glucose and 10% horse serum (Pan-Biotech)]. Hippocampi were then
mechanically dissociated with fire-polished glass-Pasteur pipettes.
Dissociated neurons were plated either at low (71 cells/mm2) or high (350 cells/mm2) density for visualization experiments or
biochemistry, respectively. For all culture conditions, neurons were allowed to attach to Poly-L-lysine-coated coverslips in the pres-
ence of MEM-HS for 2 h, which was then replaced for neuronal media (N2) (1XMEM, sodium pyruvate 1mM, Neuropan 2 supplement
1% (Pan-Biotech), NaHCO3, 0.6%glucose, 2mML-glutamine) pre-conditioned by 2-3 days incubation with a feeder layer composed
ofWT glia. While glia-conditioned N2was used in short-term cultures (12-48 h), long-term cultures (> DIV 4) required continuous sup-
port of a glial feeder layer [84].
Drugs treatments were carried out during the change to neuronal glia-conditioned N2 media [Blebbistatin 0.5 mM and 20 mM
(Sigma), Latrunculin A 5 nM and 25 nM (Biomol), Nocodazole 50 nM (Sigma) and C3T 0.5 mg/ml (Cytoskeleton)]. Glia-conditioned
N2 containing the C3T was replaced for fresh glia-conditioned N2 4 h after addition following manufacturer’s recommendations.
To note, extra care has to be taken to dilute nocodazole to avoid precipitation, which can cause toxicity and high variability in the
drug’s effective concentration.
Mixed WT [green fluorescent protein (GFP)-positive]/RhoA KO (GFP-negative) cultures were performed similarly to as previously
described [85]. In short, embryonic hippocampal neurons isolated from RhoA KO embryos were cultured alongside with WT neurons
ubiquitously expressing EGFP obtained from age-matched EGFP-mice embryos [41, 83, 85].
Unless otherwise indicated, the immunocytochemistry experiments are performed with cultured hippocampal neurons and the
neuronal extracts for immunoblot analysis were prepared from cultured cortical neurons.
DNA Constructs and siRNAs
Recombination reporters pCAG-loxSTOPlox-ZsGreen and pCAG-roxSTOProx-ZsGreen as well as pCAG-NLS-HA-Dre were a gift
from Pawel Pelczar (Addgene plasmids # 51269, 51274 and 51272 respectively [86]. To prepare pTa1-iCre and pTa1-Dre, iCre
and Dre sequences were amplified from pCAG-iCre [a gift from Wilson Wong (Addgene plasmid # 89573 [87]] and pCAG-NLS-
HA-Dre with the following primers: iCre-forward, iCre-reverse, Dre-forward and Dre-reverse (see Table S1). The amplified sequences
were later combined by overlapping PCRwith the sequence coding for the Tubulin-alpha-1 promoter (Ta1) amplified from T alpha 1p-
DsRed2 (pTa1-DsRed2) [a gift fromNicholas Gaiano (Addgene plasmid # 17707 [88];] with the primers: Ta1-forward and Ta1-reverse
(see Table S1). The assembled products were sub-cloned in a pCAGIG backbone [a gift from Connie Cepko (Addgene plasmid #
11159 [89];] in SpeI/BglII sites. The Cre/Lox recombination reporter pCAG-loxSTOPlox-LynEGFP was generated as follows: A
DNA coding EGFP fused to the membrane targeting motif of Lyn kinase (LynEGFP) was amplified from PM-GFP [a gift from Tobias
Meyer (Addgene plasmid # 21213 [90]] with the primers lox-LynEGFP-forward and lox-LynEGFP-reverse (see Table S1), and cloned
into a pCAG-loxSTOPlox-ZsGreen backbone where ZsGreen was removed between PstI/SacI sites. To generate the ‘‘mock’’ Dre/
Rox recombination reporter pCAG-roxSTOProx-LynEGFP, a roxSTOProx cassette was amplified from pCAG-roxSTOProx-ZsGreen
with the primers roxSTOP-Lyn-forward and roxSTOP-Lyn-reverse (see Table S1) and inserted into pCAG-loxSTOPlox-LynEGFP into
SalI/PstI sites replacing the loxSTOPlox cassette. To generate the pCMVd1-EGFP-hRhoA-wt plasmid, where EGFP-hRhoA is ex-
pressed under a minimal CMV promoter, EGFP-hRhoA-wt was excised from pcDNA3-EGFP-RhoA-wt [a gift from Gary Bokoch
(Addgene plasmid # 12965 [91];) with HindIII/XhoI and inserted within the same sites in a FN22K HaloTag*CMVd1FlexiVector
(Promega). For the overexpression of MLC2 CA in cultures, a bicistronic vector was prepared as follows. MLC2 CA was amplified
from pEGFP-MRLC1 T18D, S19D [a gift from Tom Egelhoff (Addgene plasmids # 35681 [92];) with the primers MLC(XhoI)-forward
and MLC(SalI)-reverse (see Table S1). PCR product was digested with XhoI/SalI and cloned into a XhoI site in a pCAGIG vector re-
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For the combined expression of LifeAct-GFP and EB3-mCherry under independent promoters, a dual CMV promoter
vector (pCMV-EB3mCherry_cmv-LifeActGFP) was generated as follow: ACMV-LifeAct-GFP-polyA cassettewas amplified fromLife-
act-GFP [53] with primers SpeI-CMV-forward 50- and BglII-EGFP-reverse (see Table S1), and inserted in SpeI/Bglll sites of pCAGIG
(pCMV-lifeAct-GFP). Then, a CMV-EB3-mCherry-polyA cassette was amplified from a EB3-mCherry plasmid [54] with primers SalI-
CMV-forward and SpeI-sv40-reverse (see Table S1), and cloned in SalI/SpeI sites of pCMV-lifeAct-GFP prepared before. Finally, to
generate a pTub-alpha1-EGFP, a pTub-alpha-1-DsRED vector was digested with NdeI/BamHI to release the Ta1 sequence that was
subsequently cloned into a pCMV-EGFP-N1 vector (Clontech) where theCMVpromoter was removed by digestionwith AseI/BglII. All
these complementary restriction sites were destroyed. All primers were from Sigma. PCRs were performed with Phusion High-Fidel-
ity PCR Master Mix (New England Biolabs). Vector Cloning was performed following the Gibson assembly method using the NEB-
uilder HiFi DNA Assembly Cloning Kit (New England Biolabs), or regular T4 ligase-based cloning (Thermo Fischer).
For gene silencing experiments, siRNA oligos (Silencer Select) and RNAi negative control were purchased from Thermo Fisher
(see Table S2).
Cell Transfections
Cell transfections were performed using a Nucleofector Device (program 0-005, Lonza) and the mouse neuron Nucleofector Kit
(Amaxa) according to the manufacturer’s specifications. 5 3 105 cells were used for each transfection with 3 mg of plasmid DNA.
All DNAs were prepared with EndoFree Maxiprep kit (QIAGEN). For the silencing experiments, 5 3 105 cells were transfected with
a mix of 0.2 pmol of the siRNA and 1 mg of neuron-specific GFP expressing plasmids (pTub-alpha1-EGFP) as carrier DNA and trans-
fection reporter.
Antibodies and dyes
Antibodies
The following primary antibodies were used: Mouse anti-bIII tubulin (Tuj1, Covance), rabbit anti-bIII tubulin (Sigma), mouse anti-Glyc-
eraldehyde 3-phosphate Dehydrogenase (GAPDH, Acris), mouse anti-Tau1 [PC1C6] (Millipore), rabbit anti-Myosin Heavy Chain IIB
(Cell Signaling), mouse anti-LIMK (BD biosciences), rabbit anti-LIMK1/2 phospoThr508/505 (Cell Signaling), rabbit anti-RhoA (Cell
Signaling), rabbit anti-RhoB (Cell Signaling), rabbit anti-RhoA (119) (Santa Cruz), mouse anti-Rac1 [23A8] (Millipore), mouse anti-
Cdc42 (Cytoskeleton), rabbit anti-Cofilin [D3F9] (Cell Signaling), rabbit anti-Cofilin phospho (Ser3) [77G2] (Cell Signaling), mouse-
anti Cofilin (Abcam), rabbit anti-Myosin light chain 2 (MLC2) (Thermo Fisher), mouse anti-MLC2 (phospho-Ser19) (Thermo Fisher),
rabbit anti-MLC2 (phosphor-Ser20) (Abcam), mouse anti-MYPT-1 (BD biosciences), rabbit anti-MYPT-1 (phospho-Thr696) (Cell
Signaling), mouse anti-SatB2 (Abcam), rabbit anti-Tbr1 (Abcam), rat anti-Ctip2 [25B6] (Abcam). The following secondary antibodies
and dyes were used: Alexa Fluor (488, 350, 647, 594 and 568), Phalloidin-Rhodamine and 4’,6-diamidino-2-phenylindole (DAPI) were
from, Thermo Fisher.; anti-mouse IgG-horse radish peroxidase (HRP) and anti-rabbit IgG-HRPwere from (GEHealthcare); Phalloidin-
Atto647N and mouse-IgG-Atto 647N were from Sigma.
Immunocytochemistry
Neuronal cultures were fixed with 4% paraformaldehyde, 4% sucrose for 20 min except for cultures used for STED microscopy,
where fixation was performed under conditions optimal for the preservation of the cytoskeleton: 4% paraformaldehyde, 4% su-
crose in PHEM fixation buffer (300 mM PIPES, 125 mM HEPES, 50 mM EGTA, 10 mM MgCl2, pH = 6.9 [63]; for 15 min. Fixed cells
were quenched with 50 mM NH4CL or 0.1 M Glycine (for fixation with PFA or PHEM respectively) for 15 min and extracted with
0.1% Triton X-100 in PBS for 5 min. The coverslips with the cells were washed three times with PBS then blocked at room tem-
perature (RT) for 1 h. Depending on the antibodies used, blocking agents were 3% Bovine Serum Albumin (BSA, Sigma; for the
antibodies bold-highlighted in the list above), blocking buffer (2% Fetal Bovine Serum (FBS, Thermo Fisher), 2% BSA and 0.2%
fish gelatin (Sigma) in PBS) or (Acetylated BSA (BSA-c, Aurion) for STED experiments. After blocking, cells were incubated with
the primary antibodies at RT for 3 h or overnight at 4C. Cells were washed three times with PBS and incubated with the sec-
ondary antibodies (1:800) at RT for 1 h. The antibodies and dyes were mixed in a 1:10 dilution of the agent used in the blocking
step. Cells were washed, rinsed and mounted onto microscope slides with FluouromountTM (Sigma) or, for STED experiments,
with ProLongTM Diamond (Thermo Fisher). Images were taken in a random fashion using an Axiovert observer D1 microscope
equipped with a high performance CCD camera (Axiocam MRn) and Zen Blue software (all from Zeiss) with the following objec-
tives: LCI Plan-Neofluar 25X/0.8 oil, Plan-Apochromat 40X/1.3 oil, Plan-Apochromat 63X/1.4 oil, and A Plan-Apochromat
100X/1.4 oil.
STED Microscopy
STED images were acquired with a TCS SP8 STED 3X equipped with a 775 nm depletion lasers and a HCX PL APO 100X/1.4 oil
Objective (Leica) using the Leica Application suite X (LAX) 3.1.5.1638 software platform. Probes labeled with AlexaFluor 647 and
Atto647N were excited with the 647 nm wavelength of a white light laser (WLL) and depleted with a continuous wave (CW)
775 nm STED laser. Probes labeled with AlexaFluor 594 were excited with the 594 wavelength of a WLL laser and depleted with a
CW 775 nm STED laser. Hybrid detectors (HyD, Leica) were used with a gating time (tg) of 0.3% tg% 6 ns. Pixel size was chosen
at 20 nm. STED images were deconvolved using Huygens Professional Deconvolution software (Scientific Volume Imaging,
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In Utero Electroporation (IUE)
Timed-pregnant mice carrying RhoAfl/fl embryos were anesthetized under a constant flow of Isoflurane (Abbot) and the uterus was
carefully exposed from the abdominal cavity. Throughout the surgery, warm saline was used to prevent dehydration. The lateral
ventricles of the embryos (E12.5 or E13.5 depending on the experiment) were filled with 2-3 ml of a 10:1 mix of EndoFree DNA
and Fast Green dye using micropipettes pulled in a pipette-puller devise (Zeitz) and a Picospritzer III microinjection device (Intracel).
The DNAs used for electroporation include pTa1-iCre, pCAG-loxSTOPlox-ZsGreen, pCAG-roxSTOProx-ZsGreen, pTa1-Dre, pCAG-
loxSTOPlox-LynEGFP and pCAG-roxSTOProx-LynEGFP. Forceps-type electrode paddles (Platinum Tweezertrode) controlled by an
ECM 830 electroporator (both from BTX Harvard Apparatus) were used to deliver 5 pulses at 35mV with 50 ms durations and 600ms
intervals. Following the electroporation of all embryos, the uterus was returned into the abdomen, which was carefully stitched. De-
pending on the experiment, themother was sacrificed at either E14.5 or E15.5. The brains were extracted from the embryos and pro-
cessed for histological analysis.
Ex Utero Electroporation (EUE) and Organotypic Culture of Brain Slices
E13.5 RhoAfl/fl embryos were extracted from the uterine sack, injected with either pair of plasmids pTa1-iCre / pCAG-loxSTOPlox-
LynEGFP or pTa1-Dre / pCAG-roxSTOProx-LynEGFP, and electroporated. The same electrodes and electroporator described for
the IUE procedure above were used to deliver 5 pulses at 54 mV with 50 ms durations and 1 s intervals. Immediately after, the heads
of the embryos were collected in Gey’s Balanced Salt Solution (GBSS, Sigma) supplemented with 0.5% glucose (GBSS-Glucose)
and the brains extracted under scope. The brains were subsequently embedded in 3% low-melting point agarose (Biozym) and
cut in 300 mm thick coronal sections (flanking the electroporated areas) using a VT1200 vibratome (Leica). Brains were always
kept and cut in cold GBSS-Glucose. The brain slices were placed on 30 mm Polytetrafluoroethylene (PTFE) membranes (Millipore)
in 35 mm transwell plates (Fluorodish, WPI) with slice media [Neurobasal 1X, FCS 5%, B27 supplement 1:50, Glutamax 1:400, peni-
cillin/streptomycin 1:200 (all from Thermo Fisher), horse serum 5%,Neuropan-2 supplement 1:100 (fromPan-Biotech) pH = 7.3]. 20 h
after culturing them, sections were imaged for additional 48 h with a DeltaVision RT (Applied Precision) live-cell imaging setup based
on an Olympus IX71 inverted microscope, with a CO2 regulated incubation chamber maintained at 35
C (Solent Scientific) and an
objective UPlanSApo 10x/0.40 infinity/0.17/FN26.5 (Olympus). Images were acquired with a Photometrics CoolSnap HQ camera
(Roper Scientific) using SoftWoRx 3.5.0 imaging software (Applied Precision). 20 mm z stack scans of multiple tiles around the areas
of interest were taken every 20 min. Stitching of the tiles was performed in ImageJ (NIH) with a custom-made script (see Key Re-
sources Table).
Immunohistochemistry
The heads of the mouse embryos were fixed in 4% paraformaldehyde, 4% sucrose in phosphate-buffered saline (PBS) at RT for
2 h and then at 4C overnight. The fixed heads were incubated in 30% sucrose in PBS for 48 h. Brain were extracted, rinsed in
PBS, embedded in Surgipath cryo-gel (Leica) and frozen. The frozen brains were then cut with a cryostate (Leica) into
25-50 mm thick coronal sections and adhered to positive charged microscopy slides (Superfrost, Thomas Scientific). The brain
sections were warmed at 37C and the cryoembedding medium washed with PBS. For nuclear staining of transcription factors,
antigen retrieval was performed by incubating the brain sections in citrate buffer (Citrate 10 mM, Glycerol 10% plus Tween
0.05% pH = 6) at 90C for 30 min in decloaking chamber (Biocare). Then, cryosections were quenched with Glycine 0.1M
for 30 min, permeabilized in 0.3% Triton X-100 for 1 h and blocked with normal goat serum (NGS, Sigma) 5% plus 0.2% Triton
X-100 in PBS (all performed at RT) for 1 h. For the nuclear staining of transcription factors, the blocking step was avoided. Sec-
tion were then incubated overnight at 4C with the primary antibodies previously diluted in 1% NGS containing 0.2% Triton
X-100 in PBS. After washing three times with PBS, cryosections were incubated with Alexa Fluor conjugated secondary anti-
bodies (1:200) at RT for 3 h. When indicated, sections were incubated with DAPI (1:20000) for 10 min. Confocal stacks were
acquired with a Plan-Apochromat 20X/0.8 air objective using a LSM700 confocal microscope (Zeiss). The maximum intensity
projection images used for display were produced using Zen software (Zeiss). Images were analyzed using ImageJ software
(NIH).
G/F-actin assay
Filamentous (F) and Globular monomeric (G) actin were fractionated from WT and RhoA KO neuronal cultures using a centrifuga-
tion-based G-actin/F-actin in-vivo assay kit (Cytoskeleton). Cultured neurons were lysed and processed according to the manu-
facturer’s guidelines. The resulting fractions were analyzed by Immunoblot using an anti-pan actin antibody provided by the kit
(Cytoskeleton).
Pull-down assays
For the determination of the active status of GTPases, we used a beads pull-down-based RhoA / Rac1 / Cdc42 Activation Assay
Combo Kit (Cytoskeleton) WT and RhoA KO neurons cultured for 20 h were lysed and processed according to the manufacturer’s
guidelines. Approximately 150-200 mg of total protein were used for each pull-down experiment. Individual culture samples were pro-
cessed separately on ice to allow complete preparation within 5 min from the removal of the culture media. The resulting fractions
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Immunoblotting
Cultured cells were lysed on ice in RIPA buffer (Millipore) containing phosphatase (PhosSTOP, Roche) and protease inhibitors (Com-
plete, Roche). Lysates were centrifuged and the supernatant collected. Protein concentration in the lysate was determined using the
Bradford Reagent (Applichem). Lysates were mixed 4:1 with 5X homemade Laemmli buffer (25% 2-Mercaptoethanol, 0.05% Bro-
mophenol blue, 50% Glycerol, 10% SDS (electrophoresis-grade), 0.31M Tris-HCl (pH 6.8)), boiled at 95C and fractioned by
3-(N-morpholino)propanesulfonic acid (MOPS)/SDS-polyacrylamide gel electrophoresis (PAGE). The separated proteins were trans-
ferred to polyvinylidene difluoride (PVDF, Millipore) membrane and stained with Ponceau S (Applichem) to verify the transfer of the
samples and confirm equal loading. Membranes were blocked at RT with 5% skimmed-milk or 5% bovine serum albumin (for anti-
bodies bold-highlighted in the list above) in Tris-Buffered Saline (TBS) plus 0.1% Tween20 (TBS-T) for 1 h. Primary antibodies were
diluted in TBS-T and incubated with the membrane for 3 h at RT or overnight at 4C. The secondary antibodies were sheep anti-
mouse or goat anti-rabbit IgG-HRP (GE Healthcare), and the blots were developed using either Pierce ECL Western Blotting Sub-
strate or SuperSignal West Dura (both from Thermo Fischer).
ROCK Activity Assay
To determine ROCK activity we used an ELISA-based 96-well ROCK assay kit (Cell Biolabs). WT and RhoA KO neurons cultured for
20 hwere lysed and processed according to themanufacturer’s guidelines. Briefly, 5 mg of total protein was incubated 30min at 30C
in presence of the ROCK substrate. The reaction mixture was washed and the in-well substrate immunolabeled following the pro-
vider’s guidelines and using the antibodies provided by the kit. Finally, the HRP-based colorimetric reaction was stopped after
10 min, and analyzed in an EnVision Multi-label plate reader (Perkin Elmer).
Live-Cell Microscopy
Live-Cell imaging
For the analysis of neuronal growth rate, 13 104 of either WT or RhoA KO neurons suspended inMEM-HSwere seeded in a chamber
of a 35 mm CELLVIEW 4-well Glass bottom culture dish (Greiner bio-one) for 2 h. Then media was changed to glia-conditioned N2.
For the drug treatments, the N2was supplemented with DMSO 0.01% (vehicle) plus Blebb 0.5 mMor C3T 0.5 mg/ml. After, Differential
imaging contrast (DIC) was performed. Images were acquired at 20 min intervals with UApon 40x/1.35 infinity/0.17/FN22 (Olympus).
Cytoskeleton Dynamics
For live-cell imaging of cytoskeleton dynamics, WT and RhoA KO neurons were transfected with a plasmid encoding the expression
of both EB3-mCherry and Lifeact-GFP. Then, 5 3 104 of either WT or RhoA KO neurons suspended in MEM-HS were seeded in
35mmglass-bottomdishes (MatTek) for 2 h.Mediawas afterward changed for glia-conditioned N2.When indicated, drug treatments
were performed as described above. Simultaneous Cherry/GFP images were acquired every 2 s for 2-5 min with a PlanApo 60x/1.42
infinity/0.17/FN26.5 objective (Olympus). All the live-cell imaging experiments were performed on a DeltaVision RT (Applied Preci-
sion) based on an Olympus IX71 inverted microscope, with a CO2 regulated incubation chamber maintained at 37
C (Solent Scien-
tific). Images were acquired with a Photometrics CoolSnap HQ camera (Roper Scientific) using SoftWoRx 3.5.0 imaging software
(Applied Precision). The plugins Kymograph_tool and MtrackJ from ImageJ were used for the analysis of actin and microtubule dy-
namics (NIH)
Whole Brain Clearing and imaging
Brain samples from wild-type and RhoA KO mice were cleared similarly as previously described [38]. Briefly, formaldehyde-fixed
brains were sectioned into 2 mm coronal segments and immersed in 15 mL of 50% (v/v with dH2O) ScaleCUBIC-1 Reagent-1A
[Urea (25 weight percent (wt%) final concentration), N,N,N,N-Tetrakis(2hydroxypropyl)ethylenediamine (Quadrol, 25 wt% final con-
centration) and Triton X-100 (15 wt% final concentration), all diluted in bi-distilled water] at room temperature overnight followed by
immersion in 15 mL of Reagent-1A at 37C with shaking for 3 days. Samples were washed with PBS and immersed in 15 mL of 50%
(v/v with PBS) ScaleCUBIC-2 [Urea (25 wt% final concentration), Sucrose (50 wt% final concentration) and Triethanolamine (10 wt%
final concentration), all diluted in bi-distilled water] at room temperature overnight and then immersed in 15 mL of ScaleCUBIC-2 at
37C with shaking for 3 days. Coronal sections of the cortex were imaged with a 2-photon microscope (LSM 7MP, Zeiss) equipped
with a Spectra Physics InSight X3 laser set at 920 nm and equipped with a 16x Nikon 0.80 numerical aperture (NA), 3.0 mm working
distance objective (N16XLWD-PF). Images were 3D-reconstructed for further analysis using Imaris 9.2 software (Bitplane).
Patch clamp electrophysiological recordings
Primary hippocampal neurons of either WT or RhoA KO mice were cultured as described above (neuronal cell culture section) and
plated in a density of 88 cells/mm2. The cells were transferred from the culturemedium to a Ringer solution containing (mM) 145NaCl,
3 KCl, 1MgCl, 1.5 CaCl2, 10HEPES, 10D-glucose (adjusted to pH 7.3with NaOH). Freshly pulled borosilicate glass pipettes (3-5MU)
were filled with an intracellular solution containing (mM) 135 K-gluconate, 10 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl2, 3 K-ATP, 0.3 Na-
GTP (adjusted to pH 7.2 with KOH). Recordings were carried out at 31-32C controlled by Temperature Controller VII (Luigs-Nemann)
in flowing Ringer solution. MultiClamp 700Bwas used to amplify and AxonDigidata 1550Bwas used to digitize (10 kHz sampling rate)
the signals (both fromMolecular Devices). Basic physiological membrane properties were assessed including resting membrane po-
tential (measured in current clamp mode) and membrane input resistance (calculated based on voltage deflection in response to
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one minute with a holding potential of 60 mV. sEPSC detection was carried out with the Axon clampfit 11 template search tool
(Molecular Devices).
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification
Data analysis was performed as follows: In culture experiments (Figures 3B–3L, 5A–5E, 7F, 7G, S2G, S3B–S3D, S3H, S3I, S4A–S4D,
and S5A–S5F), neurons without neurites or showing neurites shorter than 10 mm were considered as stage 1 (no neurites). Neurons
showing neurites longer than 10 mm without medial-to-distal accumulation of Tau-1 were considered as stage 2 (not polarized). A
neurite displaying a medial to distal accumulation of the axonal marker Tau-1 was considered an axon. Neurons that elaborate an
axon were stage 3 (polarized). Neurons exhibiting multiple axons were also considered stage 3 neurons. Total axon length refers
to the length covered by the main axon shaft plus its branches.
To analyze axon growth in time-lapse video-microscopy (Figures 5F–5H), the axon of the neurons is identified at the end of the
video, the video is rewind and the length of the neurite that originated it was measured over time using ImageJ. In this experiment,
only the length of the main axon shaft was analyzed.
To resolve the kinetic components of axonal growth (Figures 5G, 5H, and S3J), a custom-made script (see Key Resources Table)
was generated to detect growth events (one or more followed events resulting in length increases > 5 mm with tolerance for single
intermediate drop event < 1 mm), retraction events (one or more followed events resulting retractions > 5 mm in length with tolerance
for single intermediate increase event < 1 mm) and pause events (considered as followed events with length variations < 0.1 mm).
In culture cell experiments where axonal markers were not employed, the longest neurite of the neuron, at least 50 mm long, was
considered the axon (Figures 4G, 4H, 4M, 4N, 6D–6F, 7A–7E, S4E–S4J, S5G, and S5H).
In experiments where we study the formation of actin arcs in growth cones (Figures 6D, 6E, S4E, S4F, S5G, and S5H) we consid-
ered that a growth cone contained actin arcs when transversal actin dense structures, perpendicular to the exe of microtubule
growth, were present and microtubules showed preferential retention within the P-domain.
The density and extension of axon from electroporated neurons in cortical slices (Figures 2B and 2C) were determined as follows:
The limit of the electroporated area was defined as the region where the fluorescent signal is below 10% of the maximum intensity of
the whole electroporated area. Starting from this limit, a ROI was created containing the axons exiting caudally from the IZ (Figure 2C,
diagram). The imageswere then processed to transform the fluorescent signal of axons into binary lines independent of the amount of
fluorophores expressed by individual axons. For this, we used a macro containing the following functions from ImageJ: Tubeness/
Gaussian blur/Binary mask/Skeletonize. The resulting images were analyzed with the linescan/plot profile tools of ImageJ to deter-
mine the density of axons as the measured signal intensity. We performed this analysis for 2 consecutive brain slices to better span
the entire electroporated area and the values were averaged. Note that in one of the RhoA KO brains, three consecutive slices were
required for the analysis. Followed, we calculated the average distance covered by axons emanating from the electroporated region
(ER) for each brain. Then, we calculated the groups mean variance between WT and KO axons and the variance within treatments.
The resulting data were analyzedwith a CustomANOVA test (F-test). For all images, a correspondingmask of DAPI staining was used
to correct for ruptures and discontinuities in the tissue.
In organotypic cultures derived from ex utero electroporations (Figures 2D–2F), we started the time counting when a neuron
showed the first signs of MP morphology and terminated when the neuron acquired a stable BP morphology. We considered the
end of the MP-BP transition of neurons as the onset of neuronal polarity.
To determine the presence and number of axon per neuron (polarity) in the cortex and hippocampus of cleared adult brains (Figures
1D–1F) as well as in the cortical plate of embryonic brains derived from in utero electroporations (Figures S1A and S1D), we counted
all neurons in selected regions and sorted them in two groups: 1) neurons ‘‘with single axon,’’ those neurons displaying long axons or
showing a clear bipolar morphology (showing leading and trailing processes), and 2) with ‘‘no axon detected,’’ where by reasons of
low reporter signal or tissue damage we could not determine unambiguously the presence or absence of an axon or trailing process.
Therefore, we cannot exclude that a neuron labeled ‘‘no axon detected’’ may indeed have an axon. In none of the cases we found a
neuron with more than one axon.
Statistical Analysis
Statistical analysis was performed using Prism (v. 6.0; GraphPad Software) as follows: unpaired two-tailed Student’s t test (Figures
1E, 1F, 2F, 4B, 4D, 4F, 4H, 4J, 4L, 4N, 6C, 7D (black asterisks), S1D, S3H, S4A–S4D, S4F–S4H, S4J, and S5H); Mann-Whitney-test
(Figures S2D and S2E); multiple comparison by one-way ANOVA with Tukey’s post-test (Figures 3H, 3J, 3L, 5H, 6E, 6F, 7D (red as-
terisks), 7G, S2G, S3C, S3D, S3I, S3J, S5B, S5C, S5E, and S5F); ordinal logistic regression integrating time progression and correc-
tion for experimental variability (Figures 3C, 3E, 5B, and 5D; see Key Resources Table); generalized linear model (GLM) using a
Gamma distribution to account for the non-negative range of the length plus correction for confounding effects of the individual ex-
periments (Figures 3D, 3F, 5C, and 5E; see Key Resources Table); two-way ANOVA with Tukey’s post-test (Figures 5G and 7E);
customized ANOVA test (F-test) (Figure 2C; see Key Resources Table); custom-made Fisher’s permutation test corrected formultiple
comparison error by Benjamini-Hochberg procedure ([93]; see Key Resources Table) (Figure S1B). For all analyses performed, sig-
nificance was defined as *p < 0.05; **p < 0.01; ***p < 0.001 and ns, not significant.e8 Current Biology 29, 3874–3886.e1–e9, November 18, 2019
DATA AND CODE AVAILABILITY
The datasets supporting the current study have not been deposited in a public repository. The reported data are archived on file
servers at the German Center for Neurodegenerative Diseases (DZNE) and are available from the corresponding author on request.
Permutation test was performed using a custom script ‘‘permutation_test 0.18’’ implemented in Python (2.7.3 version) including
Pandas and NumPy libraries. The script is available for download in the Python Package Index (https://pypi.org/pypi/
permutation_test). CustomANOVA test (F-test) is available fromdownload at SciPy.org (http://www.scipy.org/). The script for Gener-
alized linear model (GLM) can be accessed from the R Project for Statistical Computing (https://www.R-project.org/.). The custom-
made Axon growth kinetics script for Phyton can be downloaded from (https://nextcloud.dzne.de/index.php/s/AeOZTNgco8rxp1j/
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